Article
Cholesteryl Ester Transfer Protein TaqI B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency. Veterans Affairs HDL Cholesterol Intervention Trial
Margaret E. Brousseau, John J. O'Connor, Jose M. Ordovas, Dorothea Collins, James D. Otvos, Tatyana Massov, Judith R. McNamara, Hanna B. Rubins, Sander J. Robins, Ernst J. Schaefer
https://doi.org/10.1161/01.ATV.0000024566.57589.2E
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;
Originally published June 6, 2002Margaret E. Brousseau
John J. O'Connor
Jose M. Ordovas
Dorothea Collins
James D. Otvos
Tatyana Massov
Judith R. McNamara
Hanna B. Rubins
Sander J. Robins
Jump to

This is a PDF-only article. The first page of the PDF of this article appears below.

Current Issue
Jump to
Article Tools
- Cholesteryl Ester Transfer Protein TaqI B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency. Veterans Affairs HDL Cholesterol Intervention TrialMargaret E. Brousseau, John J. O'Connor, Jose M. Ordovas, Dorothea Collins, James D. Otvos, Tatyana Massov, Judith R. McNamara, Hanna B. Rubins, Sander J. Robins and Ernst J. SchaeferArteriosclerosis, Thrombosis, and Vascular Biology. 2002;, originally published June 6, 2002https://doi.org/10.1161/01.ATV.0000024566.57589.2E
Citation Manager Formats
Share this Article
- Cholesteryl Ester Transfer Protein TaqI B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency. Veterans Affairs HDL Cholesterol Intervention TrialMargaret E. Brousseau, John J. O'Connor, Jose M. Ordovas, Dorothea Collins, James D. Otvos, Tatyana Massov, Judith R. McNamara, Hanna B. Rubins, Sander J. Robins and Ernst J. SchaeferArteriosclerosis, Thrombosis, and Vascular Biology. 2002;, originally published June 6, 2002https://doi.org/10.1161/01.ATV.0000024566.57589.2E